Allogene Therapeutics News

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chang David D

Mar 18 20:16 ET

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Parker Geoffrey M.

Mar 6 21:55 ET

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Arie Belldegrun, M.D.(5.8%),Bellco Legacy IV, LLC(2.8%), etc.

Feb 14 17:33 ET

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-David Chang, M.D., Ph.D.(5.8%),Chang 2006 Family Trust(0.7%), etc.

Feb 14 16:39 ET

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.37%)

Feb 13 17:09 ET

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)

Feb 9 08:40 ET

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer MOORE TIMOTHY L.

Jan 31 17:58 ET

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Douglas Earl Martin

Jan 31 17:58 ET

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Parker Geoffrey M.

Jan 31 17:54 ET

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Belldegrun Arie

Jan 31 17:54 ET

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Roberts Zachary

Jan 31 17:49 ET

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chang David D

Jan 31 17:43 ET

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(5.9%)

Jan 29 17:34 ET

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Roberts Zachary

Jan 24 17:31 ET

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(1.44%)

Jan 23 00:00 ET

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MESSEMER DEBORAH M.

Dec 20, 2023 16:26 ET

Allogene Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pfizer Inc. (“Pfizer”)(13.14%)

Oct 25, 2023 17:29 ET

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-CHIEF FINANCIAL OFFICER Parker Geoffrey M.

Oct 17, 2023 17:02 ET

Allogene Therapeutics | 3: Initial statement of beneficial ownership of securities-CHIEF FINANCIAL OFFICER Parker Geoffrey M.

Oct 16, 2023 19:25 ET

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-GENERAL COUNSEL Douglas Earl Martin

Aug 17, 2023 18:57 ET